Delivery Order SPE2DB22D3501-SPE2DB25FXJ99
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,440 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, with an ultimate completion date of September 19, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,278.31 on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain with a completion date of July 29, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $20,049.12 by the Defense Logistics Agency's Medical Supply Chain on April 10, 2025, with completion scheduled for April 11, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,954.56 on September 16, 2025, by the Defense Logistics Agency's Medical Supply Chain. This competitive award, with an ultimate completion date of September 17, 2025, was issued under a firm fixed-price arrangement with no set-aside designation. The contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,279.84 on September 15, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency (DLA) on September 12, 2025, with a ceiling value of $1,018.79 and an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order issued under a non-competitive, unrestricted procurement. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,784.40 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which has an ultimate completion date of August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,023.75 on July 30, 2025, by the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price delivery order is non-set-aside and scheduled for completion by July 31, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $160,951.20 on June 30, 2025, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of July 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Ultane 250 ml pen bottles. The contract has a ceiling value of $1,251.38 and is classified as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025. The place of performance is located in Conshohocken, Pennsylvania, which is also the company's corporate headquarters. This award was not set aside for small businesses or...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXJ99Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 17, 2025, from the Defense Logistics Agency (DLA) for ULTANE 250 ML in pen bottle format. This firm fixed-price, non-set-aside contract has a ceiling value of $2,310.24 and an ultimate completion date of September 18, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The DLA, which serves as the federal agency funding this procurement, relies on AmerisourceBergen as a critical vendor for medical supply chain operations serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive procurement requirements across diverse pharmaceutical categories, including specialty medications, generic drugs, vaccines, and medical devices. AmerisourceBergen's selection as a prime vendor reflects its established position within DLA's Pharmaceutical Prime Vendor Global Program, which is structured to engage multiple contractors for regional medical supply support to military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/17/25 |